Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 1-2/2008

01-10-2008

The Geo-epidemiology of Temporal (Giant Cell) Arteritis

Authors: Jennifer L. Lee, Stanley M. Naguwa, Gurtej S. Cheema, M. Eric Gershwin

Published in: Clinical Reviews in Allergy & Immunology | Issue 1-2/2008

Login to get access

Abstract

Giant cell arteritis (GCA) is the most common vasculopathy in patients over the age of 50. The majority of data on the geo-epidemiology of GCA is derived from Scandinavia, although there is very good documentation and epidemiological descriptions from studies throughout Europe and North America. There remains, however, a paucity of data on the incidence and prevalence of GCA in North American minority populations, as well as from Africa or Asia. The data that does exist suggests that the incidence of GCA is lower in Hispanic, Asian, and African American populations. It is interesting to note that as the population throughout the world continues to age, we anticipate an increased prevalence of disease based upon increases in annual incidence and improved survival. Considerable research is still needed to identify genetic, environmental, and gender-specific factors that influence not only the etiology, but also the natural history of disease.
Literature
1.
go back to reference Avrameas S, Ternynck T, Tsonis IA, Lymberi P (2007) Naturally occurring B-cell autoreactivity: a critical overview. J Autoimmun 29:213–218PubMedCrossRef Avrameas S, Ternynck T, Tsonis IA, Lymberi P (2007) Naturally occurring B-cell autoreactivity: a critical overview. J Autoimmun 29:213–218PubMedCrossRef
2.
go back to reference Cohen IR (2007) Biomarkers, self-antigens and the immunological homunculus. J Autoimmun 29:246–249PubMedCrossRef Cohen IR (2007) Biomarkers, self-antigens and the immunological homunculus. J Autoimmun 29:246–249PubMedCrossRef
3.
go back to reference Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB (2007) Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29:1–9PubMedCrossRef Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB (2007) Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29:1–9PubMedCrossRef
4.
go back to reference Lan RY, Mackay IR, Eric Gershwin M (2007) Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun 29:272–280PubMedCrossRef Lan RY, Mackay IR, Eric Gershwin M (2007) Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun 29:272–280PubMedCrossRef
5.
go back to reference Lang KS, Burow A, Kurrer M, Lang PA, Recher M (2007) The role of the innate immune response in autoimmune disease. J Autoimmun 29:206–212PubMedCrossRef Lang KS, Burow A, Kurrer M, Lang PA, Recher M (2007) The role of the innate immune response in autoimmune disease. J Autoimmun 29:206–212PubMedCrossRef
6.
go back to reference Lleo A, Invernizzi P, Selmi C, Coppel RL, Alpini G, Podda M, Mackay IR, Gershwin ME (2007) Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 29:61–68PubMedCrossRef Lleo A, Invernizzi P, Selmi C, Coppel RL, Alpini G, Podda M, Mackay IR, Gershwin ME (2007) Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 29:61–68PubMedCrossRef
7.
go back to reference Lutz HU (2007) Homeostatic roles of naturally occurring antibodies: an overview. J Autoimmun 29:287–294PubMedCrossRef Lutz HU (2007) Homeostatic roles of naturally occurring antibodies: an overview. J Autoimmun 29:287–294PubMedCrossRef
8.
go back to reference Milner J, Ward J, Keane-Myers A, Min B, Paul WE (2007) Repertoire-dependent immunopathology. J Autoimmun 29:257–261PubMedCrossRef Milner J, Ward J, Keane-Myers A, Min B, Paul WE (2007) Repertoire-dependent immunopathology. J Autoimmun 29:257–261PubMedCrossRef
9.
go back to reference Papadimitraki ED, Bertsias GK, Boumpas DT (2007) Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 29:310–318PubMed Papadimitraki ED, Bertsias GK, Boumpas DT (2007) Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 29:310–318PubMed
10.
go back to reference Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, Elkon KB (2007) Innate and adaptive immune response to apoptotic cells. J Autoimmun 29:303–309PubMedCrossRef Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, Elkon KB (2007) Innate and adaptive immune response to apoptotic cells. J Autoimmun 29:303–309PubMedCrossRef
11.
go back to reference Rowley B, Tang L, Shinton S, Hayakawa K, Hardy RR (2007) Autoreactive B-1 B cells: Constraints on natural autoantibody B cell antigen receptors. J Autoimmun 29:236–245PubMedCrossRef Rowley B, Tang L, Shinton S, Hayakawa K, Hardy RR (2007) Autoreactive B-1 B cells: Constraints on natural autoantibody B cell antigen receptors. J Autoimmun 29:236–245PubMedCrossRef
12.
go back to reference Ryan KR, Patel SD, Stephens LA, Anderton SM (2007) Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry. J Autoimmun 29:262–271PubMedCrossRef Ryan KR, Patel SD, Stephens LA, Anderton SM (2007) Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry. J Autoimmun 29:262–271PubMedCrossRef
13.
go back to reference Sanchez-Pernaute O, Ospelt C, Neidhart M, Gay S (2007) Epigenetic clues to rheumatoid arthritis. J Autoimmun 30:12–20PubMedCrossRef Sanchez-Pernaute O, Ospelt C, Neidhart M, Gay S (2007) Epigenetic clues to rheumatoid arthritis. J Autoimmun 30:12–20PubMedCrossRef
14.
go back to reference Tsonis IA, Avrameas S, Moutsopoulos HM (2007) Autoimmunity and pathophysiology. J Autoimmun 29:203–205PubMedCrossRef Tsonis IA, Avrameas S, Moutsopoulos HM (2007) Autoimmunity and pathophysiology. J Autoimmun 29:203–205PubMedCrossRef
15.
go back to reference Zelenay S, Moraes Fontes MF, Fesel C, Demengeot J, Coutinho A (2007) Physiopathology of natural auto-antibodies: the case for regulation. J Autoimmun 29:229–235PubMedCrossRef Zelenay S, Moraes Fontes MF, Fesel C, Demengeot J, Coutinho A (2007) Physiopathology of natural auto-antibodies: the case for regulation. J Autoimmun 29:229–235PubMedCrossRef
17.
go back to reference Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128PubMedCrossRef Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128PubMedCrossRef
18.
go back to reference Elling P, Olsson AT, Elling H (1996) Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol 23:112–119PubMed Elling P, Olsson AT, Elling H (1996) Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol 23:112–119PubMed
19.
go back to reference Petursdottir V, Johansson H, Nordborg E, Nordborg C (1999) The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatol (Oxf) 38:1208–1212CrossRef Petursdottir V, Johansson H, Nordborg E, Nordborg C (1999) The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatol (Oxf) 38:1208–1212CrossRef
20.
go back to reference Franzen P, Sutinen S, von Knorring J (1992) Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984–1988. J Rheumatol 19:273–276PubMed Franzen P, Sutinen S, von Knorring J (1992) Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984–1988. J Rheumatol 19:273–276PubMed
21.
go back to reference Baldursson O, Steinsson K, Bjornsson J, Lie JT (1994) Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 37:1007–1012PubMedCrossRef Baldursson O, Steinsson K, Bjornsson J, Lie JT (1994) Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 37:1007–1012PubMedCrossRef
22.
go back to reference Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, Perez-Alvarez R, Gonzalez-Juanatey C, Sanchez-Andrade A, Martin J, Llorca J (2007) Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine (Baltimore) 86:61–68CrossRef Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, Perez-Alvarez R, Gonzalez-Juanatey C, Sanchez-Andrade A, Martin J, Llorca J (2007) Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine (Baltimore) 86:61–68CrossRef
23.
go back to reference Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C, Capozzoli N, Baricchi R, Boiardi L, Chiaravalloti F et al (1991) Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 34:351–356PubMedCrossRef Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C, Capozzoli N, Baricchi R, Boiardi L, Chiaravalloti F et al (1991) Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 34:351–356PubMedCrossRef
24.
go back to reference Ramstead CL, Patel AD (2007) Giant cell arteritis in a neuro-ophthalmology clinic in Saskatoon, 1998–2003. Can J Ophthalmol 42:295–298PubMedCrossRef Ramstead CL, Patel AD (2007) Giant cell arteritis in a neuro-ophthalmology clinic in Saskatoon, 1998–2003. Can J Ophthalmol 42:295–298PubMedCrossRef
25.
go back to reference Bas-Lando M, Breuer GS, Berkun Y, Mates M, Sonnenblick M, Nesher G (2007) The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol 25:S15–S17PubMed Bas-Lando M, Breuer GS, Berkun Y, Mates M, Sonnenblick M, Nesher G (2007) The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol 25:S15–S17PubMed
26.
go back to reference Smith CA, Fidler WJ, Pinals RS (1983) The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 26:1214–1219PubMedCrossRef Smith CA, Fidler WJ, Pinals RS (1983) The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 26:1214–1219PubMedCrossRef
27.
go back to reference Salvarani C, Crowson CS, O’Fallon WM, Hunder GG, Gabriel SE (2004) Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 51:264–268PubMedCrossRef Salvarani C, Crowson CS, O’Fallon WM, Hunder GG, Gabriel SE (2004) Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 51:264–268PubMedCrossRef
28.
go back to reference Nordborg C, Johansson H, Petursdottir V, Nordborg E (2003) The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population. Rheumatol (Oxf) 42:549–552CrossRef Nordborg C, Johansson H, Petursdottir V, Nordborg E (2003) The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population. Rheumatol (Oxf) 42:549–552CrossRef
29.
go back to reference Gran JT, Myklebust G (1997) The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987–94. J Rheumatol 24:1739–1743PubMed Gran JT, Myklebust G (1997) The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987–94. J Rheumatol 24:1739–1743PubMed
30.
go back to reference Gonzalez EB, Varner WT, Lisse JR, Daniels JC, Hokanson JA (1989) Giant-cell arteritis in the southern United States. An 11-year retrospective study from the Texas Gulf Coast. Arch Intern Med 149:1561–1565PubMedCrossRef Gonzalez EB, Varner WT, Lisse JR, Daniels JC, Hokanson JA (1989) Giant-cell arteritis in the southern United States. An 11-year retrospective study from the Texas Gulf Coast. Arch Intern Med 149:1561–1565PubMedCrossRef
31.
go back to reference Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F (2007) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum 58:26–35CrossRef Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F (2007) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum 58:26–35CrossRef
32.
go back to reference Reinhold-Keller E, Zeidler A, Gutfleisch J, Peter HH, Raspe HH, Gross WL (2000) Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatol (Oxf) 39:1396–1402CrossRef Reinhold-Keller E, Zeidler A, Gutfleisch J, Peter HH, Raspe HH, Gross WL (2000) Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatol (Oxf) 39:1396–1402CrossRef
33.
go back to reference Kobayashi S, Yano T, Matsumoto Y, Numano F, Nakajima N, Yasuda K, Yutani C, Nakayama T, Tamakoshi A, Kawamura T, Ohno Y, Inaba Y, Hashimoto H (2003) Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum 49:594–598PubMedCrossRef Kobayashi S, Yano T, Matsumoto Y, Numano F, Nakajima N, Yasuda K, Yutani C, Nakayama T, Tamakoshi A, Kawamura T, Ohno Y, Inaba Y, Hashimoto H (2003) Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum 49:594–598PubMedCrossRef
34.
go back to reference Gonzalez-Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez-Camblor B, Sanchez-Andrade A (1992) Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol 19:277–280PubMed Gonzalez-Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez-Camblor B, Sanchez-Andrade A (1992) Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol 19:277–280PubMed
35.
go back to reference Lam BL, Wirthlin RS, Gonzalez A, Dubovy SR, Feuer WJ (2007) Giant cell arteritis among Hispanic Americans. Am J Ophthalmol 143:161–163PubMedCrossRef Lam BL, Wirthlin RS, Gonzalez A, Dubovy SR, Feuer WJ (2007) Giant cell arteritis among Hispanic Americans. Am J Ophthalmol 143:161–163PubMedCrossRef
36.
go back to reference Liu NH, LaBree LD, Feldon SE, Rao NA (2001) The epidemiology of giant cell arteritis: a 12-year retrospective study. Ophthalmology 108:1145–1149PubMedCrossRef Liu NH, LaBree LD, Feldon SE, Rao NA (2001) The epidemiology of giant cell arteritis: a 12-year retrospective study. Ophthalmology 108:1145–1149PubMedCrossRef
37.
go back to reference Steven MM (1992) Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands. Ann Rheum Dis 51:186–194PubMedCrossRef Steven MM (1992) Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands. Ann Rheum Dis 51:186–194PubMedCrossRef
38.
go back to reference Haugeberg G, Paulsen PQ, Bie RB (2000) Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. J Rheumatol 27:2624–2627PubMed Haugeberg G, Paulsen PQ, Bie RB (2000) Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. J Rheumatol 27:2624–2627PubMed
39.
go back to reference Smeeth L, Cook C, Hall AJ (2006) Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis 65:1093–1098PubMedCrossRef Smeeth L, Cook C, Hall AJ (2006) Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis 65:1093–1098PubMedCrossRef
Metadata
Title
The Geo-epidemiology of Temporal (Giant Cell) Arteritis
Authors
Jennifer L. Lee
Stanley M. Naguwa
Gurtej S. Cheema
M. Eric Gershwin
Publication date
01-10-2008
Publisher
Humana Press Inc
Published in
Clinical Reviews in Allergy & Immunology / Issue 1-2/2008
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-008-8075-0

Other articles of this Issue 1-2/2008

Clinical Reviews in Allergy & Immunology 1-2/2008 Go to the issue